This miR decreased epidermal growth factor receptor (EGFR) and NF-κB protein in 9L glioma cells in vitro, and inhibited small mothers against decapentaplegic (SMAD)-4, a protein of the SMAD family whose loss indicates poor outcome in glioma [103]. This evidence concerns the gene EGFR and central nervous system cancer.